Clinical Trials in the Category "Neoplasm Metastasis"
Drug Intervention Trials that are Recruiting
Study Title |
Principal Investigator | Disease Category | |
 |
|||
| Phase I Vorinostat Concurrent with Stereotactic Radiosurgery (SRS) in Brain Metastases from Non-Small Cell Lung Cancer |
John R. Adler |
Brain Cancer
Neoplasm Metastasis Lung Cancer | |
|
|||
| Phase III Study of Aflibercept vs Placebo for Metastatic Androgen-Independent Prostate Cancer |
Dr. Sandy Srinivas |
Prostatic Neoplasms
Neoplasm Metastasis | |
|
|||
Other Trials that are Recruiting
| Study Title |
Principal Investigator | Disease Category | |
|
|||
| Phase I/II Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases |
Scott Soltys Clara Choi |
Brain Cancer
Neoplasm Metastasis | |
|
|||
| PET/CT and Whole-Body MRI for Detection of Skeletal and Soft Tissue Metastases |
Sanjiv Sam Gambhir M.D., Ph.D. |
Sarcoma and Soft Tissue Cancers
Bone Cancer Neoplasm Metastasis | |
|
|||
Trials not Recruiting
| Study Title |
Principal Investigator | Disease Category | |
|
|||
|
A Phase 1b/2 Study of AMG 655 in Combination With Doxorubicin for the First-Line Treatment of Unresectable Soft Tissue Sarcoma
(No longer recruiting) |
Kristen N. Ganjoo |
Sarcoma
Neoplasm Metastasis | |
|
|||
|
Evaluation of Pathwork Tissue of Origin (TOO) test for human malignancies
(Completed) |
James L Zehnder |
Neoplasm Metastasis | |
|
|||
|
Phase II trial of bevacizumab in combination with pemetrexed as 2nd line therapy in patients with stable brain metastases from non-small cell lung cancer
(No longer recruiting) |
Heather A. Wakelee |
Neoplasm Metastasis
Lung Cancer | |
|
|||
| The physicians of the Stanford Cancer Center are engaged in more than 250 clinical trials. Contracts with some of our clinical trial sponsors prevent us from listing specific trial information on our web site. Please contact the Stanford Cancer Clinical Trials Office at 650-498-7061 for information about additional open clinical trials. |
Trial Administration